We are an integrated pharmaceutical company with a strong portfolio of niche APIs and advanced Intermediates. Viyash and its subsidiaries operate 10 manufacturing facilities with a combined capacity over 2000 KL and diversified capabilities in every aspect - small/large volume, potent / non-potent, regulated / semi-regulated markets. We have a robust R&D infrastructure with a combined network of 3 R&D facilities and over 160 scientists with expertise across several technologies and complex reactions. Diversified mix of API portfolio across multiple therapy areas such as ARV, CV, CNS, Analgesics, Antibiotics, Antihistamines, Diabetes, GI, Anticoagulants, Oncology, etc. Our strong R&D and manufacturing capabilities are based on two cornerstones that define us – High Quality and Cost efficiency..